Similar articles for PMID: 30556502

Year	Number of Results
1985	1
1994	1
1995	1
1999	1
2000	3
2004	1
2005	1
2008	1
2009	1
2013	1
2014	2
2015	7
2016	6
2017	21
2018	25
2019	24
2020	16
2021	20
2022	18
2023	4
2024	0

1

Recent Review on Subclass B1 Metallo-β-lactamases Inhibitors: Sword for Antimicrobial Resistance.

Kaushik A, Kaushik M, Lather V, Dua JS. Kaushik A, et al. Curr Drug Targets. 2019;20(7):756-762. doi: 10.2174/1389450120666181217101812. Curr Drug Targets. 2019. PMID: 30556502 Review.

2

Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.

Somboro AM, Osei Sekyere J, Amoako DG, Essack SY, Bester LA. Somboro AM, et al. Appl Environ Microbiol. 2018 Aug 31;84(18):e00698-18. doi: 10.1128/AEM.00698-18. Print 2018 Sep 15. Appl Environ Microbiol. 2018. PMID: 30006399 Free PMC article. Review.

3

Progress toward inhibitors of metallo-β-lactamases.

McGeary RP, Tan DT, Schenk G. McGeary RP, et al. Future Med Chem. 2017 May;9(7):673-691. doi: 10.4155/fmc-2017-0007. Epub 2017 May 15. Future Med Chem. 2017. PMID: 28504895 Review.

4

Recent research and development of NDM-1 inhibitors.

Wang T, Xu K, Zhao L, Tong R, Xiong L, Shi J. Wang T, et al. Eur J Med Chem. 2021 Nov 5;223:113667. doi: 10.1016/j.ejmech.2021.113667. Epub 2021 Jun 24. Eur J Med Chem. 2021. PMID: 34225181 Review.

5

4-(N-Alkyl- and -Acyl-amino)-1,2,4-triazole-3-thione Analogs as Metallo-β-Lactamase Inhibitors: Impact of 4-Linker on Potency and Spectrum of Inhibition.

Gavara L, Verdirosa F, Legru A, Mercuri PS, Nauton L, Sevaille L, Feller G, Berthomieu D, Sannio F, Marcoccia F, Tanfoni S, De Luca F, Gresh N, Galleni M, Docquier JD, Hernandez JF. Gavara L, et al. Biomolecules. 2020 Jul 23;10(8):1094. doi: 10.3390/biom10081094. Biomolecules. 2020. PMID: 32717907 Free PMC article.

6

Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.

Farhat N, Gupta D, Ali A, Kumar Y, Akhtar F, Kulanthaivel S, Mishra P, Khan F, Khan AU. Farhat N, et al. Microbiol Spectr. 2022 Oct 26;10(5):e0045022. doi: 10.1128/spectrum.00450-22. Epub 2022 Sep 7. Microbiol Spectr. 2022. PMID: 36069578 Free PMC article.

7

Development of Peptide-based Metallo-β-lactamase Inhibitors as a New Strategy to Combat Antimicrobial Resistance: A Mini-review.

Cheng Q, Zeng P, Chi Chan EW, Chen S. Cheng Q, et al. Curr Pharm Des. 2022;28(44):3538-3545. doi: 10.2174/1381612828666220929154255. Curr Pharm Des. 2022. PMID: 36177630 Review.

8

1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing Enterobacteriaceae: Exploration of Potential Metallo-β-Lactamase Inhibitors.

Somboro AM, Amoako DG, Osei Sekyere J, Kumalo HM, Khan R, Bester LA, Essack SY. Somboro AM, et al. Appl Environ Microbiol. 2019 Jan 23;85(3):e02077-18. doi: 10.1128/AEM.02077-18. Print 2019 Feb 1. Appl Environ Microbiol. 2019. PMID: 30478231 Free PMC article.

9

Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1.

Arjomandi OK, Hussein WM, Vella P, Yusof Y, Sidjabat HE, Schenk G, McGeary RP. Arjomandi OK, et al. Eur J Med Chem. 2016 May 23;114:318-27. doi: 10.1016/j.ejmech.2016.03.017. Epub 2016 Mar 9. Eur J Med Chem. 2016. PMID: 27017264

10

Tackling the Antibiotic Resistance Caused by Class A β-Lactamases through the Use of β-Lactamase Inhibitory Protein.

Eiamphungporn W, Schaduangrat N, Malik AA, Nantasenamat C. Eiamphungporn W, et al. Int J Mol Sci. 2018 Jul 30;19(8):2222. doi: 10.3390/ijms19082222. Int J Mol Sci. 2018. PMID: 30061509 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

141 results

Results by year